Applied DNA Sciences Statistics
Share Statistics
Applied DNA Sciences has 6.5M
shares outstanding. The number of shares has increased by 0.04%
in one year.
| Shares Outstanding | 6.5M |
| Shares Change (YoY) | 0.04% |
| Shares Change (QoQ) | 0.79% |
| Owned by Institutions (%) | 0.08% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | n/a |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 787.52K, so 12.12% of the outstanding
shares have been sold short.
| Short Interest | 787.52K |
| Short % of Shares Out | 12.12% |
| Short % of Float | 13.05% |
| Short Ratio (days to cover) | 1.95 |
Valuation Ratios
The PE ratio is -18.43 and the forward
PE ratio is -0.06.
Applied DNA Sciences's PEG ratio is
0.21.
| PE Ratio | -18.43 |
| Forward PE | -0.06 |
| PS Ratio | 37.55 |
| Forward PS | n/a |
| PB Ratio | 14.09 |
| P/FCF Ratio | -9.13 |
| PEG Ratio | 0.21 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Applied DNA Sciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.36,
with a Debt / Equity ratio of 0.08.
| Current Ratio | 3.36 |
| Quick Ratio | 3.17 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | -0.06 |
| Debt / FCF | -0.05 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $74,596.09 |
| Profits Per Employee | $-152,011.33 |
| Employee Count | 46 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 5.51 |
Taxes
| Income Tax | 137.3K |
| Effective Tax Rate | -1.94% |
Stock Price Statistics
The stock price has increased by null% in the
last 52 weeks. The beta is 0.39, so Applied DNA Sciences's
price volatility has been higher than the market average.
| Beta | 0.39 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 1.05 |
| 200-Day Moving Average | 17.94 |
| Relative Strength Index (RSI) | 15.46 |
| Average Volume (20 Days) | n/a |
Income Statement
In the last 12 months, Applied DNA Sciences had revenue of 3.43M
and earned -6.99M
in profits. Earnings per share was -1.82.
| Revenue | 3.43M |
| Gross Profit | 1.02M |
| Operating Income | -14.02M |
| Net Income | -6.99M |
| EBITDA | -13.33M |
| EBIT | -14.02M |
| Earnings Per Share (EPS) | -1.82 |
Full Income StatementBalance Sheet
The company has 6.43M in cash and 739.16K in
debt, giving a net cash position of 5.69M.
| Cash & Cash Equivalents | 6.43M |
| Total Debt | 739.16K |
| Net Cash | 5.69M |
| Retained Earnings | -309.67M |
| Total Assets | 13.04M |
| Working Capital | 6.54M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -13.71M
and capital expenditures -407.9K, giving a free cash flow of -14.12M.
| Operating Cash Flow | -13.71M |
| Capital Expenditures | -407.9K |
| Free Cash Flow | -14.12M |
| FCF Per Share | -3.56 |
Full Cash Flow StatementMargins
Gross margin is 29.63%, with operating and profit margins of -408.72% and -203.78%.
| Gross Margin | 29.63% |
| Operating Margin | -408.72% |
| Pretax Margin | -206.57% |
| Profit Margin | -203.78% |
| EBITDA Margin | -388.42% |
| EBIT Margin | -408.72% |
| FCF Margin | -411.47% |
